FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD - Psychiatric Times

Submitted by Anonymous (not verified) on Thu, 09/28/2023 - 07:00

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD  Psychiatric Times